List view / Grid view

News

FDA approves heart failure treatment Entresto

8 July 2015 | By Victoria White

The US Food and Drug Administration (FDA) has approved Novartis' Entresto (sacubitril/valsartan) tablets for the treatment of heart failure with reduced ejection fraction.